Immune Pharamceuticals Adds Board Member
This article was originally published in Scrip
Immune Pharmaceuticals, Inc. has appointed John Neczesny to its board of directors; he will sit on the audit committee and the compensation committee. With 27 years' experience in investment banking, Neczesny has previously been managing director at Oberon Securities, LLC. and vice president, corporate development at Par Pharmaceuticals Companies. He was also an investment banker at Bear Stearns & Co. Inc., in the Healthcare group, and later held the position of managing director.